Join our presentation at the BIO Asia-Taiwan 2024 Conference
We are proud to share that Dr. Art Hsing-Mao Chu, CEO of T-E Meds, was invited to present at the […]
Meeing
Meeing
Join our presentation at the World ADC Asia 2024 Conference
Dr. Tse Wen Chang, Chairman and CEO of Immunwork, and Dr. Art Hsing-Mao Chu, CEO of T-E Meds, have been
Reported
The 2024 Tang Prize is awarded to three scientists for the development of GLP-1
The 2024 Tang Prize in Biopharmaceutical Science has cast a spotlight on GLP-1 receptor agonists, sparking a global race among
Scientific Publication
Our latest research result is published in Advanced Science
Exciting news! Our latest published paper offers promising solutions for multiple myeloma treatment through ADC technology platform! We are thrilled
Meeing
Join Our presentation at The BiG ADC/XDC Conference
Dr. Kun-Po Li, BD Director of T-E Meds, an is set to captivate the audience at The BiG ADC/XDC Conference
Meeing
Join Our presentation at The 5th ADC Development Summit
We’re thrilled to announce that Dr. Hsing-Mao Chu, CEO of T-E Meds is honored to present at The 5th ADC
Meeing
Join Our presentation at the prestigious J.P. Morgan Healthcare Conference
Our Chairman, Dr. Tse-Wen Chang and VP of R&D, Dr. Hsing-Mao Chu are honored speakers at the prestigious J.P. Morgan
Reported
FDA approves Xolair as first and only medicine for children and adults with one or more food allergies
Congratulations to our founder, Dr. Tse-Wen Chang, the inventor of Xolair.We are thrilled to learn that Xolair’s potential benefits are extending
Reported
【Reported by Taiwan Global Bio Monthly】The president – Dr. Tse-Wen Chang shares the experiences and expectation in the “2024 Biotechnology Trends and Opportunities Forum”
Website link: https://news.gbimonthly.com/tw/article/show.php?num=64320
News
Immunwork 2024 Investor Meeting – Results Presentation
The founder of Immunwork and T-E Meds, Dr. Tse-Wen Chang, shared the latest developments of the two companies on 11th